CCK-8 contracts the gallbladder and colon through different mechanisms in the ferret.
Mitan
S
S
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
Greenwood
B
B
D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology; D002766:Cholecystokinin / Q000037:antagonists & inhibitors; D003106:Colon / Q000187:drug effects / Q000502:physiology*; D020109:Devazepide; D004305:Dose-Response Relationship, Drug; D005289:Ferrets; D005704:Gallbladder / Q000187:drug effects / Q000502:physiology*; D005769:Gastrointestinal Motility / Q000187:drug effects; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology*; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D012844:Sincalide / Q000008:administration & dosage / Q000494:pharmacology*
D001570:Benzodiazepinones; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin; C058121:L 365260; D002766:Cholecystokinin; D020109:Devazepide; D012844:Sincalide